AC Immune (ACIU) Net Cash Flow Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.94% |
| Sep 30, 2025 | 28.78% |
| Jun 30, 2025 | 21.29% |
| Mar 31, 2025 | 11.52% |
| Dec 31, 2024 | 29.95% |
| Sep 30, 2024 | -24.39% |
| Jun 30, 2024 | 60.51% |
| Mar 31, 2024 | -32.16% |
| Dec 31, 2023 | 72.97% |
| Sep 30, 2023 | -130.21% |
| Jun 30, 2023 | -51.68% |
| Mar 31, 2023 | 66.70% |
| Dec 31, 2022 | 11.91% |
| Sep 30, 2022 | -70.70% |
| Jun 30, 2022 | 32.34% |
| Mar 31, 2022 | -33.95% |
| Dec 31, 2021 | 35.84% |
| Sep 30, 2021 | -28.40% |
| Jun 30, 2021 | -89.55% |
| Mar 31, 2021 | 9.00% |
| Dec 31, 2020 | -26.00% |
| Sep 30, 2020 | 97.09% |
| Jun 30, 2020 | 17.88% |
| Mar 31, 2020 | 5.17% |
| Dec 31, 2019 | -23.79% |
| Sep 30, 2019 | -56.27% |
| Jun 30, 2019 | -45.88% |
| Mar 31, 2019 | 114.88% |
| Dec 31, 2018 | -57.37% |